Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Neurologists need to understand and be able to identify the most distinguishing features of permanent vegetative state. Virtual Mentor. 2004;6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Personal Narrative Oct 2000 Through the Patient's Eyes: Never Die Easy, Walter "Sweetness" Payton Audiey Kao, MD, PhD "But it's not in my hands anymore. It's in God's hands." Virtual Mentor. 2000;2(10):94-95. doi: 10.1001/virtualmentor.2000.2.10.prsp1-0010. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12
State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Neurologists need to understand and be able to identify the most distinguishing features of permanent vegetative state. Virtual Mentor. 2004;6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
Personal Narrative Oct 2000 Through the Patient's Eyes: Never Die Easy, Walter "Sweetness" Payton Audiey Kao, MD, PhD "But it's not in my hands anymore. It's in God's hands." Virtual Mentor. 2000;2(10):94-95. doi: 10.1001/virtualmentor.2000.2.10.prsp1-0010.